In an effort to facilitate continuity of patient care and to respond appropriately to the circumstances that have arisen during the COVID-19 pandemic, the Drug Enforcement Administration (“DEA”) has recently announced three exceptions to DEA... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | COVID-19 Resources | Life Sciences | Pharmacy Law | Physician Dispensing | Regulatory Compliance, including FDA, DEA and HIPAA | Specialty Pharmacies

Over the last few days, FDA has issued several guidance documents relating to compounding of certain aqueous injectable drugs by outsourcing facilities, State-licensed pharmacies and Federal facilities for duration of the COVID-19 public health... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | COVID-19 Resources | Healthcare | Hospitals and Healthcare Systems | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | Section 340B In-House and Contract Pharmacies

Pharmacists are frequently the first point of contact with a healthcare provider for many Americans. In an effort to implement large-scale testing for COVID-19, on April 8, 2020, the Office of the Assistant Secretary of Health, HHS, authorized... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | COVID-19 Resources | Healthcare | Laboratories | Life Sciences | Pharmacy Law | Specialty Pharmacies

In December 2019, we learned that Prime Therapeutics, LLC (“Prime”) and Express Scripts sought to begin a massive collaborative effort that would cover over 100 million Americans and was “designed to deliver more affordable care for clients... Read More
Blogs & Articles | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Specialty Pharmacies

Much of America is now entering the third week of social distancing, and with the President’s decision to extend Coronavirus mitigation guidelines through the end of April, businesses are bracing for continued interruption. Providers across the... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | COVID-19 Resources | Life Sciences | Pharmacy Law | Specialty Pharmacies

As previously discussed in our post, “What Are the PBMs Doing Amid COVID-19 Crisis: Waivers from Strict Requirements May Exist for Independent Pharmacies,” many healthcare companies alike are taking further actions to ensure that patients have... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Specialty Pharmacies

Galderma Laboratories, LP (“Galderma”) has filed numerous complaints against pharmacies all across the country alleging fraud in connection with their CareConnect Program. Galderma’s allegations are based on the pharmacies’ allegedly... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | Healthcare Litigation | Life Sciences | Pharmacy Law | Specialty Pharmacies

As New Jersey has become a hotspot in the COVID-19 outbreak, physicians and the public-at-large are looking for any remedies that may help alleviate symptoms or assist recovery.  One hot topic has been the use of hydroxychloroquine.  Originally an... Read More
Blogs & Articles | Community, Retail Pharmacies | COVID-19 Resources | Healthcare Law | Life Sciences | Pain Management Compliance | Physician Dispensing | Specialty Pharmacies

During this unprecedented time of the COVID-19 crisis, companies across every industry are taking immediate actions to help stem the spread of the virus and to ensure access to essential services.  These immediate efforts are only that much more... Read More
Blogs & Articles | Community, Retail Pharmacies | COVID-19 Resources | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Specialty Pharmacies